Infections Caused by Mycobacterium tuberculosis in Recipients of Hematopoietic Stem Cell Transplantation

Infections Caused by Mycobacterium tuberculosis in Recipients of Hematopoietic Stem Cell Transplantation

Mycobacterium tuberculosis (M. tuberculosis) infections are uncommon in recipients of hematopoietic stem cell transplantation. These infections are 10 to 40 times commoner in recipients of stem cell transplantation than in the general population but they are 10 times less in stem cell transplantatio...

Full description

Bibliographic Details
Main Authors:	Khalid Ahmed Al-Anazi, ASMA M AL-JASSER, Khalid eAlsaleh
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2014-08-01
Series:	Frontiers in Oncology
Subjects:	Drug Resistance Hematopoietic Stem Cell Transplantation Mycobacterium tuberculosis latency hematological malignancies
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fonc.2014.00231/full

Similar Items

Infections caused by Acinetobacter baumannii in recipients of hematopoietic stem cell transplantation
by: Khalid Ahmed Al-Anazi, et al.
Published: (2014-07-01)

Infections Caused by Nontuberculous Mycobacteria in Recipients of Hematopoietic Stem Cell Transplantation
by: Khalid Ahmed Al-Anazi, et al.
Published: (2014-11-01)

Infections caused by Stenotrophomonas maltophilia in recipients of hematopoietic stem cell transplantation
by: Khalid Ahmed Al-Anazi, et al.
Published: (2014-08-01)

Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies
by: Mohammad Faizan Zahid, et al.
Published: (2014-12-01)

Human Cytomegalovirus Latency and Reactivation in Allogeneic Hematopoietic Stem Cell Transplant Recipients
by: Lauren Stern, et al.
Published: (2019-05-01)

Epidemiology of Invasive Fungal Diseases in Patients with Hematologic Malignancies and Hematopoietic Cell Transplantation Recipients Managed with an Antifungal Diagnostic Driven Approach
by: Maria Daniela Bergamasco, et al.
Published: (2021-07-01)

Hematopoietic Stem Cell Niche During Homeostasis, Malignancy, and Bone Marrow Transplantation
by: Yan Man, et al.
Published: (2021-01-01)

Long-Term Dominance of Carbapenem-Non-Susceptible Pseudomonas aeruginosa ST111 in Hematologic Malignancy Patients and Hematopoietic Cell Transplant Recipients
by: Liyang Zhang, et al.
Published: (2022-06-01)

Challenges and Opportunities in Antimicrobial Stewardship among Hematopoietic Stem Cell Transplant and Oncology Patients
by: Anjali Majumdar, et al.
Published: (2023-03-01)

Infections caused by mycobacterium tuberculosis in patients with hematological disorders and in recipients of hematopoietic stem cell transplant, a twelve year retrospective study
by: Al-Jasser Asma, et al.
Published: (2007-11-01)

Prognostic factors of second hematopoietic allogeneic stem cell transplantation among hematological malignancy patients relapsed after first hematopoietic stem cell transplantation: A single center study
by: Yue Lu, et al.
Published: (2023-01-01)

Reconstitution of T Cell Subsets Following Allogeneic Hematopoietic Cell Transplantation
by: Linde Dekker, et al.
Published: (2020-07-01)

Populations of latent Mycobacterium tuberculosis lack a cell wall: Isolation, visualization, and whole-genome characterization
by: Ali Akbar Velayati, et al.
Published: (2016-01-01)

Blood and blood products to support allogeneic hematopoietic progenitor cell transplant recipients at king abdulaziz medical city-Riyadh – Transfusion medicine services
by: Ahmed Al Harbi, et al.
Published: (2022-01-01)

Tuberculosis in Liver Transplant Recipients: A Report of Eight Cases During a Five Year Period
by: Diana Póvoas, et al.
Published: (2017-01-01)

Why and How Should Ethiopia Establish a Stem Cell Transplant Service? A Review Article
by: Mekonnen S, et al.
Published: (2023-03-01)

Rare tuberculosis in recipients of allogeneic hematopoietic stem cell transplantation successfully treated with contezolid–a typical case report and literature review
by: Junhong Li, et al.
Published: (2023-10-01)

Aspectos biológicos, clínicos y epidemiológicos de la tuberculosis latente: Biological, clinical and epidemiological aspects of latent tuberculosis
by: Jorge A Barrios-Payán, et al.
Published: (2010-02-01)

Healthcare utilization and cost of cancer-related care prior to allogeneic hematopoietic cell transplantation for hematologic malignancies in the US: a retrospective real-world analysis
by: Machaon Bonafede, et al.
Published: (2021-10-01)

Mycobacterium Tuberculosis Infection after Kidney Transplantation: A Comprehensive Review
by: Bogdan Marian Sorohan, et al.
Published: (2022-09-01)

Thymopoiesis in Pre- and Post-Hematopoietic Stem Cell Transplantation
by: Luis Klaus A. da Rocha, et al.
Published: (2018-09-01)

Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies
by: Xuan Li, et al.
Published: (2012-08-01)

Disseminated cutaneous infection due to Mycobacterium chelonae following hematopoietic stem cell transplantation
by: C. Ferry, et al.
Published: (2014-01-01)

Should the BCRA1/2-mutations healthy carriers be valid candidates for hematopoietic stem cell donation?
by: Alberto Fresa, et al.
Published: (2021-04-01)

Latent Tuberculosis Infection in Potential Renal Transplant Recipients and Live Donors in a Tertiary Level Transplant Center in Nepal
by: Suresh Maharjan, et al.
Published: (2022-12-01)

Tuberculosis in renal transplant recipients
by: Madhivanan Sundaram, et al.
Published: (2008-01-01)

Infections in Hematopoietic Stem Cell Transplant Recipients and Prevention
by: Ayşegül YEŞİLKAYA, et al.
Published: (2006-06-01)

Cognitive impairments in patients with hematological malignancies prior and after allogeneic hematopoietic stem cells transplantation
by: D. E. Vybornykh, et al.
Published: (2019-07-01)

Clinical Significance of microRNAs in Hematologic Malignancies and Hematopoietic Stem Cell Transplantation
by: Aneta Sevcikova, et al.
Published: (2023-05-01)

A New Benzothiazolthiazolidine Derivative, 11726172, Is Active In Vitro, In Vivo, and against Nonreplicating Cells of Mycobacterium tuberculosis
by: Elena G. Salina, et al.
Published: (2022-12-01)

Preventive effects of Mycobacterium tuberculosis DNA vaccines on the mouse model with latent tuberculosis infection
by: Yan Liang, et al.
Published: (2023-02-01)

Impact of natural killer cells on outcomes after allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis
by: Muhammad Umair Mushtaq, et al.
Published: (2022-10-01)

Fecal Microbiota Transplant Mitigates Adverse Outcomes Seen in Patients Colonized With Multidrug-Resistant Organisms Undergoing Allogeneic Hematopoietic Cell Transplantation
by: Andrew J. Innes, et al.
Published: (2021-08-01)

Post-Transplant Complications in Patients Undergoing Autologous Hematopoietic Cell Transplantation (HCT)—A Comparative Analysis of Home Care versus Hospitalized Patients
by: Ana María Garcés-Carrasco, et al.
Published: (2023-12-01)

Endocrine and Metabolic Disorders after Hematopoietic Cell Transplantation
by: Annalisa Paviglianiti
Published: (2020-05-01)

Cognitive impairment in patients with hematological malignancies at a long-term period after the transplantation of allogeneic hematopoietic stem cells
by: D. E. Vybornykh, et al.
Published: (2020-04-01)

Sexual Function in Women Survivors of Hematologic Malignancy after Autologous Hematopoietic Stem Cell Transplantation
by: Ioanna Tsatsou, et al.
Published: (2023-03-01)

Anti-Thymocyte Globulin Prophylaxis in Patients With Hematological Malignancies Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: An Updated Meta-Analysis
by: Xue Yang, et al.
Published: (2021-08-01)

Clinical considerations at the intersection of hematopoietic cell transplantation and hereditary hematopoietic malignancy
by: Timothy E. O’Connor, et al.
Published: (2023-05-01)

Tuberculosis patients co-infected with Mycobacterium bovis and Mycobacterium tuberculosis in an urban area of Brazil
by: Marcio Roberto Silva, et al.
Published: (2013-05-01)